233 related articles for article (PubMed ID: 8853395)
1. Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats.
Havel PJ; Busch BL; Curry DL; Johnson PR; Dallman MF; Stern JS
Am J Physiol; 1996 Sep; 271(3 Pt 2):R710-7. PubMed ID: 8853395
[TBL] [Abstract][Full Text] [Related]
2. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats.
Langley SC; York DA
Am J Physiol; 1990 Sep; 259(3 Pt 2):R539-44. PubMed ID: 2204281
[TBL] [Abstract][Full Text] [Related]
3. The effects of the acute administration of RU 486 on dietary fat preference in fasted lean and obese men.
Kramlik SK; Altemus M; Castonguay TW
Physiol Behav; 1993 Oct; 54(4):717-24. PubMed ID: 8248349
[TBL] [Abstract][Full Text] [Related]
4. Differential hypothalamic arginine vasopressin response to glucocorticoid receptor antagonism in lean and obese Zucker rats.
Pesonen U; Jolkkonen J; Huupponen R; Koulu M
Neuroendocrinology; 1992 Aug; 56(2):271-7. PubMed ID: 1407382
[TBL] [Abstract][Full Text] [Related]
5. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats.
Al-Barazanji KA; Arch JR; Buckingham RE; Tadayyon M
Obes Res; 2000 Jul; 8(4):317-23. PubMed ID: 10933308
[TBL] [Abstract][Full Text] [Related]
6. Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough.
Walker CD; Scribner KA; Stern JS; Dallman MF
Endocrinology; 1992 Dec; 131(6):2629-37. PubMed ID: 1332842
[TBL] [Abstract][Full Text] [Related]
7. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G
Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453
[TBL] [Abstract][Full Text] [Related]
8. Effect of adrenalectomy and glucocorticoid replacement on development of obesity.
Freedman MR; Horwitz BA; Stern JS
Am J Physiol; 1986 Apr; 250(4 Pt 2):R595-607. PubMed ID: 3515971
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats.
Livingstone DE; Kenyon CJ; Walker BR
J Endocrinol; 2000 Dec; 167(3):533-9. PubMed ID: 11115781
[TBL] [Abstract][Full Text] [Related]
10. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
11. Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats.
Alemzadeh R; Holshouser S
Endocrinology; 1999 Jul; 140(7):3197-202. PubMed ID: 10385415
[TBL] [Abstract][Full Text] [Related]
12. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats.
Barat P; Livingstone DE; Elferink CM; McDonnell CR; Walker BR; Andrew R
Endocrinology; 2007 Oct; 148(10):4836-43. PubMed ID: 17628001
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of lean fetal hypothalamus restores hypothalamic function in Zucker obese rats.
Fukagawa K; Knight DS; Price HV; Sakata T; Tso P
Am J Physiol; 1996 Jul; 271(1 Pt 2):R55-63. PubMed ID: 8760204
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats.
Pesonen U; Rouru J; Huupponen R; Koulu M
Brain Res Mol Brain Res; 1991 Jun; 10(3):267-72. PubMed ID: 1653393
[TBL] [Abstract][Full Text] [Related]
15. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
[TBL] [Abstract][Full Text] [Related]
16. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of the genetically obese mouse to corticosterone.
Tokuyama K; Himms-Hagen J
Am J Physiol; 1987 Feb; 252(2 Pt 1):E202-8. PubMed ID: 3548420
[TBL] [Abstract][Full Text] [Related]
18. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
Livingstone DE; Walker BR
J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
[TBL] [Abstract][Full Text] [Related]
19. Responsiveness of isolated adrenocortical cells from lean and obese Zucker rats to ACTH.
White BD; Davenport WD; Porter JR
Am J Physiol; 1988 Sep; 255(3 Pt 1):E229-35. PubMed ID: 3421323
[TBL] [Abstract][Full Text] [Related]
20. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats.
Cettour-Rose P; Rohner-Jeanrenaud F
Endocrinology; 2002 Jun; 143(6):2277-83. PubMed ID: 12021192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
